gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to methods for producing antibodies.
|
gptkbp:applicationNumber
|
10/2003/123456
|
gptkbp:applicationPublication
|
gptkb:US_2003/0123456_A1
|
gptkbp:applicationStatus
|
published
|
gptkbp:applicationType
|
utility
|
gptkbp:assignee
|
gptkb:Genentech,_Inc.
|
gptkbp:citedBy
|
gptkb:US_7,123,456_B2
|
gptkbp:claims
|
20
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:description
|
This patent describes methods for producing antibodies using recombinant DNA technology.
|
gptkbp:examiner
|
Jane_Smith
|
gptkbp:expirationDate
|
September 14, 2024
|
gptkbp:field
|
immunology
|
gptkbp:fieldOfInvention
|
biotechnology
|
gptkbp:fieldOfUse
|
medical research
|
gptkbp:filingDate
|
March 15, 2003
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,021 C29
|
gptkbp:internationalClassification
|
C07K 16/28
|
gptkbp:inventor
|
gptkb:Alice_Johnson
gptkb:John_Doe
|
gptkbp:issueDate
|
September 14, 2004
|
gptkbp:issuedOn
|
September 14, 2004
|
gptkbp:legalStatus
|
granted
|
gptkbp:patentAssignee
|
gptkb:Genentech,_Inc.
|
gptkbp:patentCitation
|
gptkb:US_5,789,012_A
|
gptkbp:patentClassification
|
biotechnology
|
gptkbp:patentFamily
|
US_6,789,021
|
gptkbp:patentFamilyMembers
|
gptkb:US_6,789,028_E7
gptkb:US_6,789,031_H0
gptkb:US_6,789,025_B4
gptkb:US_6,789,026_C5
gptkb:US_6,789,022_B1
gptkb:US_6,789,023_C2
gptkb:US_6,789,029_F8
gptkb:US_6,789,030_G9
US 6,789,024 A3
US_6,789,027_D6
|
gptkbp:patentNumber
|
6,789,021
|
gptkbp:patentOffice
|
gptkb:USPTO
|
gptkbp:patentType
|
utility patent
granted patent
|
gptkbp:priorityDate
|
March 15, 2001
|
gptkbp:relatedPatent
|
gptkb:US_6,123,456_A1
|
gptkbp:relatedTo
|
antibody production
|
gptkbp:status
|
active
|
gptkbp:technology
|
monoclonal antibodies
|
gptkbp:title
|
Methods for producing antibodies
|